Eli M. Wallace

Insider Reports History

Location
South San Francisco, CA
Signature
/s/ Aaron Chan, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Eli M. Wallace:

Company Role Class Num Shares Value Price $ Report Date Ownership
BridgeBio Oncology Therapeutics, Inc. Chief Executive Officer, Director Stock Option (Right to Buy) 1,114,400 01 Jan 2026 Direct

Insider Reports Filed by Eli M. Wallace

Symbol Company Period Transactions Value $ Form Type Role Filing Time
HLXB BridgeBio Oncology Therapeutics, Inc. 01 Jan 2026 1 $0 4 Chief Executive Officer, Director 05 Jan 2026, 19:22
HLXB BridgeBio Oncology Therapeutics, Inc. 10 Dec 2025 1 $0 4 Chief Executive Officer, Director 12 Dec 2025, 19:04
HLXB BridgeBio Oncology Therapeutics, Inc. 02 Oct 2025 1 $0 4 Chief Executive Officer, Director 06 Oct 2025, 16:22
HLXB BridgeBio Oncology Therapeutics, Inc. 26 Aug 2025 1 $0 4 Chief Executive Officer, Director 28 Aug 2025, 16:36
HLXB BridgeBio Oncology Therapeutics, Inc. 11 Aug 2025 0 $0 3 Chief Executive Officer, Director 18 Aug 2025, 17:10